Uncategorized - October 30, 2013
EU funded effort to develop new stroke therapies
The COUNTERSTROKE consortium led by researchers at Karolinska Institutet today initiates a six million Euro EU funded collaboration to develop novel therapeutics to treat stroke. Stroke and other conditions related to a decreased oxygen supply to the brain are the third most common cause of death in Europe. One out of three stroke incidents lead […]
Uncategorized - October 25, 2013
Improved cytostatic therapy for children
Researchers at Karolinska Institutet in Sweden and colleagues at University Children’s Hospital Z-rich in Switzerland have managed to improve cytostatic therapy for children with the chronic immune deficiency disorder granulomatous disease prior to stem cell transplantation. By tailoring doses of the cytostatics administered before the transplantation, the researchers achieved a higher rate of survival with […]
Uncategorized - October 22, 2013
Shionogi provides funding for Danish research
Shionogi Co has selected Denmark as one of the countries in their Shionogi Science Program 2013. Shionogi Science Program invites researchers from selected countries outside Japan into joint studies. The aim is to invite novel, innovative and world-class ideas from researchers to create new pharmaceuticals. The program will adopt projects with budgets of JPY 5-15 […]
Collaboration - October 22, 2013
AstraZeneca and Evotec launche research collaboration
AstraZeneca and Evotec have launched a research collaboration focused on developing new drugs for kidney disease, the second partnership involving entities of the pharma giant and the German drug discovery alliance and development partnership company. The value of the collaboration was not disclosed. Evotec will license a series of molecules identified by its own drug-discovery […]
Uncategorized - October 7, 2013
Individualized cancer treatment
The new Centre for Cancer Biomarkers (CCBIO) at the University of Bergen will conduct in-depth studies of the microenvironment of cancerous tumours, hunting for biomarkers to aid physicians in selecting the best targeted treatment. One of the CCBIO centre’s strengths is that its activities encompass the entire value chain from basic to applied research. Research […]
Uncategorized - September 30, 2013
New methods to treat heroin addiction
What is it about heroin that brings about such a pronounced effect? A number of research projects funded under the Programme on Alcohol and Drug Research (RUSMIDDEL) at the Research Council of Norway may help to solve the mystery. “Gaining a thorough understanding of the effects of heroin and of the neurobiological mechanisms involved will […]
